Response to “On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021”

Petrice M. Cogswell, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Clifford R. Jack

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article number118992
StatePublished - May 1 2022

ASJC Scopus subject areas

  • Neurology
  • Cognitive Neuroscience

Cite this